These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32924431)

  • 21. Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein.
    Kingston NJ; Kurtovic L; Walsh R; Joe C; Lovrecz G; Locarnini S; Beeson JG; Netter HJ
    Vaccine; 2019 Mar; 37(12):1674-1684. PubMed ID: 30773400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice.
    Cai X; Zheng W; Pan S; Zhang S; Xie Y; Guo H; Wang G; Li Z; Luo M
    Antiviral Res; 2018 Jan; 149():48-57. PubMed ID: 29129705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris.
    Freivalds J; Dislers A; Ose V; Pumpens P; Tars K; Kazaks A
    Protein Expr Purif; 2011 Feb; 75(2):218-24. PubMed ID: 20854910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering Metastability into a Virus-like Particle to Enable Triggered Dissociation.
    Starr CA; Nair S; Huang SY; Hagan MF; Jacobson SC; Zlotnick A
    J Am Chem Soc; 2023 Feb; 145(4):2322-2331. PubMed ID: 36651799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.
    Alam MK; Brabant M; Viswas RS; Barreto K; Fonge H; Ronald Geyer C
    BMC Biotechnol; 2018 Sep; 18(1):55. PubMed ID: 30200951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen.
    Tekewe A; Fan Y; Tan E; Middelberg AP; Lua LH
    Biotechnol Bioeng; 2017 Feb; 114(2):397-406. PubMed ID: 27497268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-Like Particle Engineering: From Rational Design to Versatile Applications.
    Ding X; Liu D; Booth G; Gao W; Lu Y
    Biotechnol J; 2018 May; 13(5):e1700324. PubMed ID: 29453861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a yeast-based VLP platform for antigen presentation.
    Wetzel D; Rolf T; Suckow M; Kranz A; Barbian A; Chan JA; Leitsch J; Weniger M; Jenzelewski V; Kouskousis B; Palmer C; Beeson JG; Schembecker G; Merz J; Piontek M
    Microb Cell Fact; 2018 Feb; 17(1):17. PubMed ID: 29402276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.
    Ho JK; Jeevan-Raj B; Netter HJ
    Viruses; 2020 Jan; 12(2):. PubMed ID: 31973017
    [No Abstract]   [Full Text] [Related]  

  • 31. Meeting report VLPNPV: Session 5: Plant based technology.
    Meador LR; Mor TS
    Hum Vaccin Immunother; 2014; 10(10):3068-73. PubMed ID: 25581535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.
    Yong CY; Yeap SK; Goh ZH; Ho KL; Omar AR; Tan WS
    Appl Environ Microbiol; 2015 Feb; 81(3):882-9. PubMed ID: 25416760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles.
    Tang S; Xuan B; Ye X; Huang Z; Qian Z
    Sci Rep; 2016 May; 6():25741. PubMed ID: 27170066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.
    Ko C; Bester R; Zhou X; Xu Z; Blossey C; Sacherl J; Vondran FWR; Gao L; Protzer U
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine.
    Chuan YP; Rivera-Hernandez T; Wibowo N; Connors NK; Wu Y; Hughes FK; Lua LH; Middelberg AP
    Biotechnol Bioeng; 2013 Sep; 110(9):2343-51. PubMed ID: 23532896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
    Liu D; Li B; Bi C; Qiao H; Wu X
    Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subunit Protein Vaccine Delivery System for Tuberculosis Based on Hepatitis B Virus Core VLP (HBc-VLP) Particles.
    Dhanasooraj D; Kumar RA; Mundayoor S
    Methods Mol Biol; 2016; 1404():377-392. PubMed ID: 27076312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.